Volume 42, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



A recombinant DNA sporozoite vaccine containing the repeating region of the Salvador I strain circumsporozoite (CS) protein was produced in . This vaccine was tested in 13 naive volunteers at doses of 10–1,000 µg. No serious adverse reactions were noted. None of 4 volunteers receiving the 10 µg dose developed antibodies measurable by ELISA. Six of 9 volunteers in the other dose groups developed measurable antibodies: 5 of 5 volunteers receiving 100 µg and 1 of 4 receiving 1,000 µg. Antibody responses measured by immunofluorescence assays paralleled those seen by ELISA. None of the volunteers developed antisera that inhibited sporozoite invasion of human hepatoma cells in vitro. Lack of a classical anamnestic response and lack of a typical dose response to increasing amounts of antigen suggests the possible presence of an immunosuppressive epitope in the repetitive region of the CS protein.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error